Methods for treating occlusive crisis associated with sickle cell disease

JP2026053572APending Publication Date: 2026-03-25NICOX SA
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Filing Date
2025-12-24
Publication Date
2026-03-25

Smart Images

  • Figure 2026053572000002
    Figure 2026053572000002
  • Figure 2026053572000003
    Figure 2026053572000003
  • Figure 2026053572000001
    Figure 2026053572000001
Patent Text Reader

Abstract

This provides treatment for vascular occlusive crisis (VOC) associated with sickle cell anemia. [Solution] A 4-(nitrooxy)butyl(2S)-2-(6-methoxy-2-naphthyl)propanoate is provided for use in the treatment of occlusive crisis in patients with sickle cell anemia.
Need to check novelty before this filing date? Find Prior Art